Turning Point Therapeutic...

NASDAQ: TPTX · Real-Time Price · USD
75.49
0.09 (0.12%)
At close: Aug 15, 2022, 10:00 PM

Turning Point Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
30.83M
Cost of Revenue
n/a
Gross Profit
30.83M
Operating Income
-236.55M
Interest Income
n/a
Pretax Income
-236.55M
Net Income
-236.55M
Selling & General & Admin
75.85M
Research & Development
192.98M
Other Expenses
n/a
Operating Expenses
268.83M
Interest Expense
n/a
Selling & Marketing Expenses
n/a
Cost & Expenses
268.83M
Income Tax Expense
1.45M
Shares Outstanding (Basic)
40.84M
Shares Outstanding (Diluted)
40.84M
EPS (Basic)
-5.79
EPS (Diluted)
-5.79
EBITDA
-232.58M
EBIT
-236.55M
Depreciation & Amortization
3.97M